226 related articles for article (PubMed ID: 20853113)
1. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study.
Skau M; Sander B; Milea D; Jensen R
J Neurol; 2011 Feb; 258(2):277-83. PubMed ID: 20853113
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348
[TBL] [Abstract][Full Text] [Related]
3. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
4. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
Vosoughi AR; Margolin EA; Micieli JA
J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic intracranial hypertension is not benign: a long-term outcome study.
Yri HM; Wegener M; Sander B; Jensen R
J Neurol; 2012 May; 259(5):886-94. PubMed ID: 22008872
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema.
Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP
Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220
[TBL] [Abstract][Full Text] [Related]
7. Update on Idiopathic Intracranial Hypertension.
Wall M
Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
[TBL] [Abstract][Full Text] [Related]
8. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
9. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.
Rebolleda G; Muñoz-Negrete FJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5197-200. PubMed ID: 19011007
[TBL] [Abstract][Full Text] [Related]
11. OCT for optic disc evaluation in idiopathic intracranial hypertension.
Skau M; Milea D; Sander B; Wegener M; Jensen R
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):723-30. PubMed ID: 20949278
[TBL] [Abstract][Full Text] [Related]
12. The Relationship between Lumbar Puncture Opening Pressure and Retinal Nerve Fiber Layer Thickness in the Diagnosis of Idiopathic Intracranial Hypertension: Is a Lumbar Puncture Always Necessary?
Kaya Tutar N; Kale N
Neurologist; 2024 Mar; 29(2):91-95. PubMed ID: 37839079
[TBL] [Abstract][Full Text] [Related]
13. Impact of Pregnancy on Papilledema and Vision Loss in Idiopathic Intracranial Hypertension Patients: A Chart Review and Case Series of 13 Patients.
Lambert-Cheatham NA; Nagia L; Pasmanter NR; Pellizzari R; Lee B; Miller NJ; Kaufman DI
J Neuroophthalmol; 2024 Jun; 44(2):206-211. PubMed ID: 37540562
[TBL] [Abstract][Full Text] [Related]
14. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
[TBL] [Abstract][Full Text] [Related]
15. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension.
Vijay V; Mollan SP; Mitchell JL; Bilton E; Alimajstorovic Z; Markey KA; Fong A; Walker JK; Lyons HS; Yiangou A; Tsermoulas G; Brock K; Sinclair AJ
JAMA Ophthalmol; 2020 Dec; 138(12):1264-1271. PubMed ID: 33090189
[TBL] [Abstract][Full Text] [Related]
16. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
17. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
18. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension.
Heckmann JG; Faschingbauer F; Lang C; Reulbach U; Dütsch M; Mardin CY; Schwab S
J Neurosurg; 2007 Sep; 107(3):543-7. PubMed ID: 17886553
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Albrecht P; Blasberg C; Ringelstein M; Müller AK; Finis D; Guthoff R; Kadas EM; Lagreze W; Aktas O; Hartung HP; Paul F; Brandt AU; Methner A
J Neurol; 2017 Jul; 264(7):1370-1380. PubMed ID: 28584914
[TBL] [Abstract][Full Text] [Related]
20. Measurement of Choroid Thickness Using Optical Coherence Tomography to Monitor Intracranial Pressure in an Idiopathic Cranial Hypertension Model.
Ozdemir I; Çevik S
Neurol India; 2020; 68(3):636-639. PubMed ID: 32643677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
